| Returns | 1W : 4.7% , 1M : -6.3%,1Y : -1.8% |
| Peers & Returns | 1W | 1M | 1Y |
| BLISS GVS PHARMA | 4.7% | -6.3% | -1.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.2% | 11.4% | 36.3% |
| DR REDDYS LABORATORIES | 7.4% | 23.5% | 34.1% |
| DIVIS LABORATORIES | -0.8% | 14.8% | 61.7% |
| CIPLA | 3.3% | 25.1% | 62.3% |
| BIOCON | -1.2% | 2.6% | 12.1% |
| AUROBINDO PHARMA | 8.6% | 23.1% | 82.7% |
| LUPIN | 1.1% | 6.1% | 34.7% |
| TORRENT PHARMACEUTICALS | 0.4% | 8.8% | 11.6% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
10.67
P/E Calculated based on EPS of 9.43
[ Mar2020 - Consolidated Results ] 1.41
P/B Calculated based on Book Value of 71.32
[ Mar2020 - Consolidated Results ] 1.89
P/S Calculated based on Revenues of 548.744 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
52% -12% -12% |
| Pledged Shares |
0.33 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 3.7% | 15.3% | 56.9% |
| S&P BSE SMALL CAP | 0.5% | 2.5% | 90.8% |
| S&P BSE MIDSMALLCAP | 0.2% | 1.7% | 80% |
| S&P BSE 400 MIDSMALLCAP | 0% | 1% | 81% |
| S&P BSE 250 SMALLCAP | -0.2% | 0.1% | 87.8% |
| S&P BSE ALLCAP | -0.8% | -0.3% | 59.7% |
| S&P BSE 500 | -0.9% | -0.4% | 58.8% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 | 0.3% | 1% | 90.9% |
| NIFTY MID SMALL400 | -0.1% | 0.9% | 80.8% |
| NIFTY 500 | -0.9% | -0.4% | 58.3% |
